Research ArticleArticle
Enhancement of Doxorubicin Cytotoxicity on Human Esophageal Squamous Cell Carcinoma Cells by Indomethacin and 4-[5-(4-Chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC236) via Inhibiting P-Glycoprotein Activity
Le Yu, William Ka Kei Wu, Zhi Jie Li, Qi Cai Liu, Hai Tao Li, Ya Chun Wu and Chi Hin Cho
Molecular Pharmacology June 2009, 75 (6) 1364-1373; DOI: https://doi.org/10.1124/mol.108.053546
Le Yu
William Ka Kei Wu
Zhi Jie Li
Qi Cai Liu
Hai Tao Li
Ya Chun Wu
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Enhancement of Doxorubicin Cytotoxicity on Human Esophageal Squamous Cell Carcinoma Cells by Indomethacin and 4-[5-(4-Chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC236) via Inhibiting P-Glycoprotein Activity
Le Yu, William Ka Kei Wu, Zhi Jie Li, Qi Cai Liu, Hai Tao Li, Ya Chun Wu and Chi Hin Cho
Molecular Pharmacology June 1, 2009, 75 (6) 1364-1373; DOI: https://doi.org/10.1124/mol.108.053546
Research ArticleArticle
Enhancement of Doxorubicin Cytotoxicity on Human Esophageal Squamous Cell Carcinoma Cells by Indomethacin and 4-[5-(4-Chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC236) via Inhibiting P-Glycoprotein Activity
Le Yu, William Ka Kei Wu, Zhi Jie Li, Qi Cai Liu, Hai Tao Li, Ya Chun Wu and Chi Hin Cho
Molecular Pharmacology June 1, 2009, 75 (6) 1364-1373; DOI: https://doi.org/10.1124/mol.108.053546
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement